Target intelligence / Profile preview

Bacterial ribonuclease P (RNase P)

Target
RNase P
Molecular classification
Enzyme, Ribozyme, Ribonucleoprotein
01

Overview

Bacterial ribonuclease P (RNase P) is an essential ribonucleoprotein enzyme found in all bacteria, where it catalyzes the site-specific cleavage of the 5'-leader sequence from precursor transfer RNA (tRNA) molecules (Altman, 2007). This maturation step is critical for the translation machinery and overall protein synthesis. The bacterial holoenzyme is typically composed of a single catalytic RNA (P RNA) and a single small protein (P protein), a simpler architecture compared to the multi-protein eukaryotic versions (Gopalan et al., 2018). Due to its essentiality and the structural divergence between bacterial and human RNase P, it is considered a high-priority target for the development of new classes of antibiotics. Inhibiting RNase P leads to the accumulation of non-functional tRNA precursors, effectively arresting bacterial metabolism and growth. Therapeutic strategies include small molecule inhibitors, such as Irresistin-16, and antisense oligonucleotides designed to disrupt the catalytic RNA component (Liu et al., 2020).

Other names
Ribonuclease PRNase PRNPrnpBrnpAtRNA-processing ribonuclease P
02

Mechanism of action

Inhibition of the catalytic RNA component or the protein-RNA interaction of the RNase P holoenzyme, preventing the 5'-end maturation of precursor tRNAs and thereby disrupting bacterial protein synthesis (Altman, 2007; Gopalan et al., 2018).

03

Biological functions

tRNA processingRNA maturationProtein synthesis regulation
04

Disease associations

Infection
05

Safety considerations

Cross-reactivity with human mitochondrial or nuclear RNase PChallenges in achieving sufficient intracellular concentration in Gram-negative bacteriaPotential for rapid development of resistance through mutations in rnpA or rnpB genes
06

Interacting drugs

Irresistin-16

2 more in the full profile.

07

Biomarkers

Precursor tRNA levelsBacterial growth inhibition

Beyond the preview

Go deeper on Bacterial ribonuclease P (RNase P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial ribonuclease P (RNase P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call